These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 2379457

  • 1. Effects of cellular fixatives on human immunodeficiency virus production.
    Cory JM, Rapp F, Ohlsson-Wilhelm BM.
    Cytometry; 1990; 11(5):647-51. PubMed ID: 2379457
    [Abstract] [Full Text] [Related]

  • 2. Fixation of mammalian cells for flow cytometric evaluation of DNA content and nuclear immunofluorescence.
    Schimenti KJ, Jacobberger JW.
    Cytometry; 1992; 13(1):48-59. PubMed ID: 1372202
    [Abstract] [Full Text] [Related]

  • 3. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins.
    Pollice AA, McCoy JP, Shackney SE, Smith CA, Agarwal J, Burholt DR, Janocko LE, Hornicek FJ, Singh SG, Hartsock RJ.
    Cytometry; 1992; 13(4):432-44. PubMed ID: 1382010
    [Abstract] [Full Text] [Related]

  • 4. Effect of D-penicillamine on the expression and propagation of the human immunodeficiency virus by H9 T-lymphoblastoid cells.
    Bitterlich G, Larcher C, Sölder B, Hengster P, Myones BL, Hofbauer J, Schulz TF, Wachter H, Dierich MP.
    Arzneimittelforschung; 1989 Aug; 39(8):825-8. PubMed ID: 2818669
    [Abstract] [Full Text] [Related]

  • 5. The effect of interferon on cells persistently infected with HIV.
    Crespi M.
    AIDS; 1989 Jan; 3(1):33-6. PubMed ID: 2496710
    [Abstract] [Full Text] [Related]

  • 6. Detection of human immunodeficiency virus-infected lymphoid cells at low frequency by flow cytometry.
    Cory JM, Ohlsson-Wilhelm BM, Brock EJ, Sheaffer NA, Steck ME, Eyster ME, Rapp F.
    J Immunol Methods; 1987 Dec 04; 105(1):71-8. PubMed ID: 2445828
    [Abstract] [Full Text] [Related]

  • 7. Effects of whole blood lysis and fixation on the infectivity of human T-lymphotropic virus type 1 (HTLV-I).
    Ericson JG, Trevino AV, Toedter GP, Mathes LE, Newbound GC, Lairmore MD.
    Cytometry; 1994 Mar 15; 18(1):49-54. PubMed ID: 8082486
    [Abstract] [Full Text] [Related]

  • 8. Rapid single-step method for flow cytometric detection of surface and intracellular antigens using whole blood.
    Francis C, Connelly MC.
    Cytometry; 1996 Sep 01; 25(1):58-70. PubMed ID: 8875055
    [Abstract] [Full Text] [Related]

  • 9. Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations.
    Chow S, Hedley D, Grom P, Magari R, Jacobberger JW, Shankey TV.
    Cytometry A; 2005 Sep 01; 67(1):4-17. PubMed ID: 16080188
    [Abstract] [Full Text] [Related]

  • 10. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M, Fikkert V, Pluymers W, Matthews B, Mardel K, Schols D, Raff J, Debyser Z, De Clercq E, Holan G, Pannecouque C.
    Mol Pharmacol; 2000 Nov 01; 58(5):1100-8. PubMed ID: 11040059
    [Abstract] [Full Text] [Related]

  • 11. HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells.
    Martin SJ, Matear PM, Vyakarnam A.
    J Immunol; 1994 Jan 01; 152(1):330-42. PubMed ID: 7902858
    [Abstract] [Full Text] [Related]

  • 12. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.
    Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M, Kulkosky J, Duan LX, Pomerantz RJ.
    J Hum Virol; 2000 Oct 10; 3(1):6-15. PubMed ID: 10774802
    [Abstract] [Full Text] [Related]

  • 14. Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells.
    Barnor JS, Miyano-Kurosaki N, Yamaguchi K, Sakamoto A, Ishikawa K, Inagaki Y, Yamamoto N, Osei-Kwasi M, Ofori-Adjei D, Takaku H.
    Biochem Biophys Res Commun; 2004 Jul 23; 320(2):544-50. PubMed ID: 15219863
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-18 enhances HIV-1 production in a human chronically-infected T cell line (H9-V).
    Pugliese A, Gennero L, Vidotto V, Speranza F, Tambini R, Torre D.
    Cell Biochem Funct; 2002 Dec 23; 20(4):333-7. PubMed ID: 12415568
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.
    Davis DA, Branca AA, Pallenberg AJ, Marschner TM, Patt LM, Chatlynne LG, Humphrey RW, Yarchoan R, Levine RL.
    Arch Biochem Biophys; 1995 Sep 10; 322(1):127-34. PubMed ID: 7574666
    [Abstract] [Full Text] [Related]

  • 17. Ability of 'OptiLyse' lysing/fixing reagents to inactivate HIV-infected H9 cells in whole blood.
    Nicholson JK, Browning SW.
    J Immunol Methods; 1994 Feb 10; 168(2):283-4. PubMed ID: 8308303
    [No Abstract] [Full Text] [Related]

  • 18. Tropism of human immunodeficiency virus 1 isolates for H9 cells and U937 cells.
    Cory JM, Ohlsson-Wilhelm BM, Rapp F.
    Intervirology; 1990 Feb 10; 31(2-4):101-8. PubMed ID: 2373608
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of HIV-infected H9 cells in whole blood preparations by lysing/fixing reagents used in flow cytometry.
    Nicholson JK, Browning SW, Orloff SL, McDougal JS.
    J Immunol Methods; 1993 Apr 02; 160(2):215-8. PubMed ID: 8459108
    [Abstract] [Full Text] [Related]

  • 20. Liposomes modulate human immunodeficiency virus infectivity.
    Konopka K, Davis BR, Larsen CE, Alford DR, Debs RJ, Düzgüneş N.
    J Gen Virol; 1990 Dec 02; 71 ( Pt 12)():2899-907. PubMed ID: 2273389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.